Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma
CANCERS（2021）
Key words
hepatocellular carcinoma,immunotherapy,PD-1,PD-L1,immune check-point inhibitor,combination therapy,CD8 T cell response
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined